The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release

Virology

Volumn 237, Issue 1, 1997, Pages 46-55

  Lee, Yung Hui ^a   Schwartz, Michael D ^a   Panganiban, Antonito T ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS PARTICLE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030660074     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8711     Document Type: Article

References (67)

1. Bour S., Schubert U., Peden K., Strebel K. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: A Vpu-like factor. J. Virol. 70:1996;820-829.
2. Bour S., Schubert U., Strebel K. The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: Implications for the mechanism of degradation. J. Virol. 69:1995;1510-1520.
3. Bray M., Prasad S., Dubay J. W., Hunter E., Jeang K. T., Rekosh D., Hammarskjold M. L. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl. Acad. Sci. USA. 91:1994;1256-1260.
4. Buonocore L., Turi T. G., Crise B., Rose J. K. Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology. 204:1994;482-486.
5. M. A. Callahan, M. A. Handley, K. K. Talbot, Y.-H. Lee, J. W. Harper, A. T. Panganiban, A novel member of the tetratricopeptide repeat protein family functionally interacts with human immunodeficiency virus-type 1 Vpu and Gag proteins.
6. Casella C. R., Raffini L. J., Panganiban A. T. Pleiotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication. Virology. 228:1997;294-306.
7. Chatterjee S., Basak S., Khan N. C. Morphogenesis of human immunodeficiency virus type 1. Pathobiology. 60:1992;181-186.
8. Checroune F., Yao X. J., Gottlinger H. G., Bergeron D., Cohen E. A. Incorporation of Vpr into human immunodeficiency virus type 1: Role of conserved regions within the P6 domain of Pr55gag. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10:1995;1-7.
9. Chen M. Y., Maldarelli F., Karczewski M. K., Willey R. L., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: The cytoplasmic domain of CD4 contributes to Vpu sensitivity. J. Virol. 67:1993;3877-3884.
10. Cohen E. A., Dehni G., Sodroski J. G., Haseltine W. A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64:1990;3097-3099.
11. Dorfman T., Mammano F., Haseltine W. A., Gottlinger H. G. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1994;1689-1696.
12. Franke E. K., Yuan H. E. H., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature. 372:1994;359-362.
13. Freed E. O., Martin M. A. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69:1995;1984-1989.
14. Freed E. O., Martin M. A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70:1996;341-351.
15. Freed E. O., Orenstein J. M., Buckler W. A., Martin M. A. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:1994;5311-5320.
16. Friborg J., Ladha A., Gottlinger H., Haseltine W. A., Cohen E. A. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 8:1995;10-22.
17. Friborg J., Yao X. J., Boisvert F., Garzon S., Cohen E. A. Mutational analysis of the HIV-1 Vpu protein. Leukemia. 8:1994;S156-162.
18. Gelderblom H. R. Assembly and morphology of HIV: Potential effect of structure on viral function. AIDS. 5:1991;617-638.
19. Gelderblom H. R., Hausmann E. H. S., Ozel M., Pauli G., Koch M. A. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology. 156:1987;171-176.
20. Geleziunas R., Bour S., Wainberg M. A. Cell surface down-modulation of CD4 after infection by HIV-1. FASEB J. 8:1994;593-600.
21. Geraghty R. J., Panganiban A. T. Human immunodeficiency virus type 1 Vpu has a CD4- and an envelope glycoprotein-independent function. J. Virol. 67:1993;4190-4194.
22. Geraghty R. J., Talbot K. J., Callahan M., Harper W., Panganiban A. T. Cell type-dependence for Vpu function. J. Med. Primatol. 23:1994;146-150.
23. Gheysen D., Jacobs E., De F. F., Thiriart C., Francotte M., Thines D., De W. M. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell. 59:1989;103-112.
24. Gottlinger H. G., Dorfman T., Cohen E. A., Haseltine W. A. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl. Acad. Sci. USA. 90:1993;7381-7385.
25. Gottlinger H. G., Sodroski J. G., Haseltine W. A. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 86:1989;5781-5785.
26. Haseltine W. A. Molecular biology of the human immunodeficiency virus type 1. FASEB J. 5:1991;2349-2360.
27. Henklein P., Schubert U., Kunert O., Klabunde S., Wray V., Kloppel K. D., Kiess M., Portsmann T., Schomburg D. Synthesis and characterization of the hydrophilic C-terminal domain of the human immunodeficiency virus type 1-encoded virus protein U (Vpu). Pept. Res. 6:1993;79-87.
28. Jabbar M. A. The human immunodeficiency virus type 1 Vpu protein: Roles in virus release and CD4 downregulation. Curr. Top. Microbiol. Immunol. 193:1995;107-120.
29. Kaplan A. H., Swanstrom R. HIV-1 gag proteins are processed in two cellular compartments. Proc. Natl. Acad. Sci. USA. 88:1991;4528-4532.
30. Karczewski M. K., Strebel K. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol. 70:1996;494-507.
31. Kimura T., Nishikawa M., Ohyama A. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: Vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum. J. Biochem. 115:1994;1010-1020.
32. Klimkait T., Strebel K., Hoggan M. D., Martin M. A., Orenstein J. M. The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release. J. Virol. 64:1990;621-629.
33. Kondo E., Mammano F., Cohen E. A., Gottlinger H. G. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 69:1995;2759-2764.
34. Lavallee C., Yao X. J., Ladha A., Gottlinger H., Haseltine W. A., Cohen E. A. Requirement of the Pr55Gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J. Virol. 68:1994;1926-1934.
35. Lenburg M. E., Landau N. R. Vpu-induced degradation of CD4: Requirement for specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 67:1993;7238-7245.
36. Lu Y. L., Spearman P., Ratner L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67:1993;6542-6550.
37. Luban J., Bossolt K. L., Franke E. K., Kalpana G. V., Goff S. P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell. 73:1993;1067-1078.
38. Maldarelli F., Chen M. Y., Willey R. L., Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67:1993;5056-5061.
39. McBride M. S., Panganiban A. T. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70:1996;2963-2973.
40. Raja N. U., Vincent M. J., Abdul J. M. Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: Requirement of both the anchor and cytoplasmic domains of CD4. Virology. 204:1994;357-366.
41. Rasmussen L., Battles J. K., Ennis W. H., Nagashima K., Gonda M. A. Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus. Virology. 178:1990;435-451.
42. Ritter G. D. J., Yamshchikov G., Cohen S. J., Mulligan M. J. Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: Role of the cytoplasmic domain. J. Virol. 70:1996;2669-2673.
43. Schubert U., Bour S., Ferrer-Montiel A. V., Montal M., Maldarelli F., Strebel K. The two biological activities of human immunodeficiency virus type I Vpu protein involve two separable structure domains. J. Virol. 70:1996;809-819.
44. Schubert U., Clouse K. A., Strebel K. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69:1995;7699-7711.
45. Schubert U., Henklein P., Boldyreff B., Wingender E., Strebel K., Porstmann T. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J. Mol. Biol. 236:1994;16-25.
46. Schubert U., Schneider T., Henklein P., Hoffmann K., Berthold E., Hauser H., Pauli G., Porstmann T. Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. Eur. J. Biochem. 204:1992;875-883.
47. Schubert U., Strebel K. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68:1994;2260-2271.
48. Schwartz M. D., Geraghty R. J., Panganiban A. T. HIV-1 particle release mediated by Vpu is distinct from that mediated by p6. Virology. 224:1996;302-309.
49. Schwartz S., Felber B. K., Benko D. M., Fenyo E. M., Pavlakis G. N. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64:1990;2519-2529.
50. Spearman P., Wang J. J., Vander H. N., Ratner L. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:1994;3232-3242.
51. Strambio-de-Castillia C., Hunter E. Mutational analysis of the major homology region of Mason-Pfzer monkey virus by use of saturation mutagenesis. J. Virol. 66:1992;7021-7032.
52. Strebel K., Klimkait T., Maldarelli F., Martin M. A. Molecular and biochemical analyses of human immunodeficiency virus type 1 Vpu protein. J. Virol. 63:1989;3784-3791.
53. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C. T., Sodroski J., Gottlinger H. G. Functional association of cyclophilin A with HIV-1 virions [see comments]. Nature. 372:1994;363-365.
54. Vincent M. J., Raja N. U., Jabbar M. A. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: Role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J. Virol. 67:1993;5538-5549.
55. Wang C. T., Barklis E. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J. Virol. 67:1993;4264-4273.
56. Weaver T. A., Panganiban A. T. N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation. J. Virol. 64:1990;3995-4001.
57. Willey R. L., Buckler W. A., Strebel K. Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein. J. Virol. 68:1994;1207-1212.
58. Willey R. L., Maldarelli F., Martin M. A., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66:1992a;7193-7200.
59. Willey R. L., Maldarelli F., Martin M. A., Strebel K. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66:1992b;226-234.
60. Wills J. W., Craven R. C. Form, function, and use of retroviral Gag proteins. AIDS. 5:1991;639-654.
61. Wray V., Federau T., Henklein P., Klabunde S., Kunert O., Schomburg D., Schubert U. Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy. Int. J. Pept. Protein Res. 45:1995;35-43.
62. Yao X. J., Friborg J., Checroune F., Gratton S., Boisvert F., Sekaly R. P., Cohen E. A. Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: A predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. Virology. 209:1995;615-623.
63. Yao X. J., Gottlinger H., Haseltine W. A., Cohen E. A. Envelope glycoprotein and CD4 independence of Vpu-facilitated human immunodeficiency virus type 1 capsid export. J. Virol. 66:1992;5119-5126.
64. Yu X., Yuan X., Matsuda Z., Lee T. H., Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66:1992;4966-4971.
65. Yuan X., Matsuda Z., Matsuda M., Essex M., Lee T. H. Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res. Hum. Retroviruses. 6:1990;1265-1271.
66. Yuan X., Yu X., Lee T. H., Essex M. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 67:1993;6387-6394.
67. Zhou W., Parent L. J., Wills J. W., Resh M. D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:1994;2556-2569.